Global Bio-based MDI Market Growth 2026-2032

October 2026 | 96 pages | ID: G3A78CBB5C84EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Bio-based MDI market size is predicted to grow from US$ 87.16 million in 2025 to US$ 365 million in 2032; it is expected to grow at a CAGR of 22.8% from 2026 to 2032.

Bio-Based MDI refers to methylene diphenyl diisocyanate manufactured using renewable, biomass-derived, or bio-circular feedstocks, with the renewable characteristics incorporated through physical segregation or certified mass-balance allocation. The market primarily covers polymeric MDI, monomeric MDI, modified MDI, and MDI-based resin grades supplied with verifiable renewable-feedstock attribution. Its industrial production retains the established MDI process chain, in which aromatic intermediates are converted into aniline, condensed with formaldehyde to produce methylene diphenyl diamine, and subsequently phosgenated into MDI. Renewable substitution generally occurs in upstream hydrocarbon, benzene, biomethane, or energy inputs, allowing Bio-Based MDI to maintain processing properties broadly comparable with conventional MDI. Key purchasing specifications include MDI product form, NCO content, viscosity, renewable attribution percentage, product carbon footprint, certification scheme, and supply format. Bio-Based MDI is principally used in rigid and flexible polyurethane foams, building and refrigeration insulation, engineered-wood binders, adhesives, sealants, elastomers, automotive components, footwear, synthetic leather, and other polyurethane systems requiring lower attributed lifecycle emissions.

Key Findings

Global Bio-Based MDI Shipments Reached Approximately 27,000 Metric Tons In 2025

The Weighted Average FOB Price Was Approximately USD 3,300 Per Metric Ton

Certified Mass-Balance MDI Was The Dominant Commercial Product Route Across The Market

Market Trends

The Bio-Based MDI market is evolving from isolated sustainability projects into a structured low-carbon product category integrated within existing MDI production and polyurethane formulation systems. Certified mass balance has become the principal commercialization route because it enables producers to introduce renewable or bio-circular feedstocks into large, technically complex production networks while retaining conventional product specifications and downstream processing compatibility. Product development is progressing from general biomass-balanced polymeric MDI toward differentiated monomeric, modified, automotive seating, insulation, adhesive, and engineered-wood grades with specified renewable attribution levels and product carbon-footprint data. Suppliers are also moving beyond certification alone by combining renewable feedstock allocation with lower-emission energy, carbon-footprint verification, customer-specific documentation, and application development. Downstream customers increasingly require materials that can be introduced without reformulation, production-line modification, or additional performance qualification. Consequently, future product competition will focus less on whether certified Bio-Based MDI can be supplied and more on the renewable attribution percentage, feedstock origin, audited carbon reduction, regional availability, documentation quality, and the supplier’s ability to support finished-product environmental claims.

Market Dynamics

Drivers

Demand growth is being driven by the decarbonization targets of construction-material, appliance, automotive, furniture, adhesive, footwear, and synthetic-leather customers. Bio-Based MDI offers a relatively direct method of lowering attributed upstream emissions because it can generally replace conventional MDI without materially changing polyurethane processing conditions or finished-product performance. European building regulations are also increasing attention to embodied carbon and lifecycle global warming potential, strengthening the commercial relevance of lower-carbon insulation boards, adhesives, sealants, and composite-wood materials. Large downstream groups are increasingly incorporating product carbon footprints and Scope 3 emissions into procurement decisions, supporting contract demand for certified renewable-attributed MDI.

Restraints

The principal restraints are the limited availability and price volatility of qualified renewable feedstocks, certification and auditing expenses, and the premium customers must pay relative to conventional MDI. Bio-Based MDI remains connected to the conventional MDI cost structure, including benzene, aniline, chlorine, energy, logistics, and plant-utilization rates, while adding renewable-feedstock and chain-of-custody costs. Adoption is also constrained by differences in how customers, regulators, and procurement systems interpret mass-balance claims. Because certified and conventional feedstocks may be physically mixed during production, the allocated renewable percentage cannot necessarily be confirmed by testing an individual product batch, making traceability documentation and claim wording critical to commercial acceptance.

Opportunities

The strongest opportunities lie in applications where MDI represents a limited portion of finished-product cost but contributes materially to the product carbon footprint. Building insulation, refrigeration equipment, cold-chain panels, engineered wood, reactive adhesives, premium footwear, automotive seating, and export-oriented synthetic leather are therefore attractive early-adoption markets. Additional opportunities are emerging from higher renewable attribution grades, bio-circular feedstocks derived from waste and residues, customer-specific product carbon-footprint solutions, and integrated polyurethane systems combining Bio-Based MDI with renewable or recycled polyols. Expansion of certified production sites in Asia and North America could also reduce regional freight requirements and improve the availability of locally sourced low-carbon polyurethane raw materials.

Challenges

The industry must establish consistent terminology and credible environmental claims as the distinction among physically bio-based, biomass-balanced, bio-attributed, and bio-circular products becomes increasingly important. Suppliers face the challenge of scaling renewable-feedstock procurement without competing excessively with fuels, food-related resources, or other chemical applications. The market is also exposed to conventional MDI oversupply and cyclical price declines, which can widen the relative green premium and delay customer conversion. Long-term commercial success will depend on independently audited allocation systems, comparable product carbon-footprint boundaries, stable contractual pricing mechanisms, and the ability to demonstrate measurable downstream value rather than relying solely on certification labels.

Industry Chain Analysis

The upstream chain begins with agricultural and forestry residues, waste oils, biological intermediates, bio-naphtha, biomethane, renewable electricity, and other certified alternative inputs. These resources are converted through refining and basic chemical processes into renewable-attributed aromatic feedstocks, benzene, aniline precursors, energy, and supporting chemicals. Conventional inputs such as formaldehyde, chlorine, carbon monoxide, catalysts, and process utilities remain essential. Feedstock origin, conversion losses, certification eligibility, and chain-of-custody accounting determine the amount of renewable attribute that can ultimately be assigned to Bio-Based MDI. Renewable raw materials and certification represent incremental costs, but the underlying MDI value chain remains dominated by integrated plant scale, energy efficiency, operating rates, and access to aromatic intermediates.

At the midstream stage, integrated chemical producers synthesize, separate, blend, and modify MDI before assigning certified renewable attributes to polymeric, monomeric, or modified grades. Value creation is concentrated in production technology, highly regulated chemical handling, operational reliability, certification management, product carbon-footprint calculation, and application support. Downstream system houses and formulators combine Bio-Based MDI with polyols, catalysts, blowing agents, fillers, and additives to produce polyurethane systems. Finished-product manufacturers capture additional value by converting the lower-carbon raw-material attributes into differentiated insulation, adhesives, wood panels, automotive parts, footwear, and other products supported by auditable environmental documentation.

Segment Insights

Polymeric MDI represents the principal commercial product segment because rigid polyurethane and polyisocyanurate insulation, refrigeration systems, composite-wood binders, and construction adhesives provide relatively clear carbon-reduction value propositions and established high-volume processing platforms. Monomeric and modified MDI grades form a smaller but strategically important segment serving elastomers, coatings, adhesives, automotive seating, footwear, and specialized polyurethane systems. These products generally require more precise viscosity, functionality, purity, and processing specifications, creating opportunities for differentiated pricing and closer technical cooperation between suppliers and customers.

By renewable implementation route, certified mass-balance Bio-Based MDI accounts for the dominant share of current commercial supply. Physically segregated MDI made from directly traceable biological carbon remains limited because the aromatic MDI chain involves multiple integrated conversion stages and large production assets. Grades with higher renewable attribution, verified bio-circular feedstocks, and reduced cradle-to-gate carbon footprints are expected to gain importance in premium applications. However, customers will continue to select products based on a combination of technical performance, documented emission reduction, availability, and total formulation cost rather than renewable percentage alone.

Downstream Market Opportunities

Construction and thermal insulation constitute the most visible initial market opportunity because rigid polyurethane and polyisocyanurate systems use substantial quantities of MDI and face growing scrutiny of embodied emissions. Refrigerators, freezers, cold rooms, refrigerated transportation, and industrial insulation provide a related opportunity where energy-efficiency benefits can be combined with lower attributed material emissions. Engineered wood and reactive adhesive applications are commercially attractive because the green premium can be distributed across a comparatively high-value finished product. Automotive interiors, seating, footwear, synthetic leather, coatings, sealants, and elastomers offer additional growth potential as brand owners introduce product-level carbon targets and certified material procurement requirements.

Regional Insights

Europe currently has the clearest commercial environment for Bio-Based MDI, supported by established mass-balance certification systems, mature polyurethane value chains, corporate carbon-reduction commitments, and increasing regulatory attention to lifecycle emissions from buildings and construction materials. Demand is concentrated in insulation, construction adhesives, engineered wood, appliances, and premium industrial formulations. The planned disclosure of lifecycle global warming potential for new buildings is expected to improve demand visibility for polyurethane materials with verified product carbon-footprint reductions, although adoption rates will differ among countries and applications.

North America is developing through customer-specific projects in insulation boards, recreational surfacing, adhesives, appliances, and domestically certified polyurethane supply chains. Asia-Pacific has substantial long-term expansion potential because it combines major MDI production capacity with large footwear, synthetic-leather, appliance, automotive, and export-manufacturing industries. China has established certified MDI production capability, while demand development is increasingly linked to multinational customer requirements and the carbon documentation of exported finished products. The market remains too early for a reliable definitive ranking of regional growth rates, and actual expansion will depend on local renewable-feedstock availability, customer willingness to pay, and the recognition of mass-balance claims.

Competitive Landscape Analysis

The Bio-Based MDI market has a highly concentrated supply structure because commercial production depends on existing world-scale MDI assets, integrated aromatic intermediates, complex process safety capabilities, and internationally recognized chain-of-custody certification. The verified competitive group consists of BASF, Covestro, Dow, Huntsman, and Wanhua Chemical. BASF has established a differentiated offering through Lupranat ZERO and biomass-balanced grades with detailed product carbon-footprint positioning. Covestro maintains a broad portfolio of bio-attributed and bio-circular Desmodur CQ products covering multiple renewable attribution levels and applications. Dow supplies REN-branded MDI grades and has expanded certified production availability in North America. Huntsman combines certified mass-balance MDI capability with downstream MDI resin development for engineered wood and other applications. Wanhua Chemical has obtained ISCC PLUS certification for MDI and provides an important certified supply platform in China, although publicly disclosed Bio-Based MDI branding and renewable attribution specifications remain more limited. Competitive differentiation is expected to center on certified feedstock access, regional supply coverage, product breadth, carbon-footprint documentation, application development, and the ability to maintain commercially acceptable premiums over conventional MDI rather than on nominal MDI capacity alone.

Report Scope

LP Information, Inc. (LPI) ' newest research report, the “Bio-based MDI Industry Forecast” looks at past sales and reviews total world Bio-based MDI sales in 2025, providing a comprehensive analysis by region and market sector of projected Bio-based MDI sales for 2026 through 2032. With Bio-based MDI sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bio-based MDI industry.

This Insight Report provides a comprehensive analysis of the global Bio-based MDI landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bio-based MDI portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bio-based MDI market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bio-based MDI and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bio-based MDI.

This report presents a comprehensive overview, market shares, and growth opportunities of Bio-based MDI market by product type, application, key manufacturers and key regions and countries.

Market Segmentation

Segmentation by Type:

  • Polymeric MDI
  • Monomeric MDI
  • Modified MDI
  • Others

Segmentation by Feedstock Origin:

  • Lignin-based MDI
  • Sugar/Carbohydrate-derived MDI
  • Others

Segmentation by Renewable Attribute Route:

  • Mass Balance
  • Bio-Circular Mass Balance
  • Physically Segregated
  • Others

Segmentation by Application:

  • Construction Engineering
  • Automobile Manufacturing
  • Shoe Manufacturing
  • Household Goods
  • Others

This report also splits the market by region:

  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • BASF SE
  • Covestro AG
  • Dow Inc.
  • Huntsman Corporation
  • LANXESS
  • Wanhua Chemical Group Co., Ltd.

Key Questions Addressed in this Report

  • What is the 10-year outlook for the global Bio-based MDI market?
  • What factors are driving Bio-based MDI market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Bio-based MDI market opportunities vary by end market size?
  • How does Bio-based MDI break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Bio-based MDI Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Bio-based MDI by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Bio-based MDI by Country/Region, 2021, 2025 & 2032
2.2 Bio-based MDI Segment by Type
  2.2.1 Polymeric MDI
  2.2.2 Monomeric MDI
  2.2.3 Modified MDI
  2.2.4 Others
  2.2.5 Bio-based MDI Sales by Type
    2.2.5.1 Global Bio-based MDI Sales Market Share by Type (2021-2026)
    2.2.5.2 Global Bio-based MDI Revenue and Market Share by Type (2021-2026)
    2.2.5.3 Global Bio-based MDI Sale Price by Type (2021-2026)
2.3 Bio-based MDI Segment by Feedstock Origin
  2.3.1 Lignin-based MDI
  2.3.2 Sugar/Carbohydrate-derived MDI
  2.3.3 Others
  2.3.4 Bio-based MDI Sales by Feedstock Origin
    2.3.4.1 Global Bio-based MDI Sales Market Share by Feedstock Origin (2021-2026)
    2.3.4.2 Global Bio-based MDI Revenue and Market Share by Feedstock Origin (2021-2026)
    2.3.4.3 Global Bio-based MDI Sale Price by Feedstock Origin (2021-2026)
2.4 Bio-based MDI Segment by Renewable Attribute Route
  2.4.1 Mass Balance
  2.4.2 Bio-Circular Mass Balance
  2.4.3 Physically Segregated
  2.4.4 Others
  2.4.5 Bio-based MDI Sales by Renewable Attribute Route
    2.4.5.1 Global Bio-based MDI Sales Market Share by Renewable Attribute Route (2021-2026)
    2.4.5.2 Global Bio-based MDI Revenue and Market Share by Renewable Attribute Route (2021-2026)
    2.4.5.3 Global Bio-based MDI Sale Price by Renewable Attribute Route (2021-2026)
2.5 Bio-based MDI Segment by Application
  2.5.1 Construction Engineering
  2.5.2 Automobile Manufacturing
  2.5.3 Shoe Manufacturing
  2.5.4 Household Goods
  2.5.5 Others
  2.5.6 Bio-based MDI Sales by Application
    2.5.6.1 Global Bio-based MDI Sale Market Share by Application (2021-2026)
    2.5.6.2 Global Bio-based MDI Revenue and Market Share by Application (2021-2026)
    2.5.6.3 Global Bio-based MDI Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Bio-based MDI Breakdown Data by Company
  3.1.1 Global Bio-based MDI Annual Sales by Company (2021-2026)
  3.1.2 Global Bio-based MDI Sales Market Share by Company (2021-2026)
3.2 Global Bio-based MDI Annual Revenue by Company (2021-2026)
  3.2.1 Global Bio-based MDI Revenue by Company (2021-2026)
  3.2.2 Global Bio-based MDI Revenue Market Share by Company (2021-2026)
3.3 Global Bio-based MDI Sale Price by Company
3.4 Key Manufacturers Bio-based MDI Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Bio-based MDI Product Location Distribution
  3.4.2 Players Bio-based MDI Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR BIO-BASED MDI BY GEOGRAPHIC REGION

4.1 World Historic Bio-based MDI Market Size by Geographic Region (2021-2026)
  4.1.1 Global Bio-based MDI Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Bio-based MDI Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Bio-based MDI Market Size by Country/Region (2021-2026)
  4.2.1 Global Bio-based MDI Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Bio-based MDI Annual Revenue by Country/Region (2021-2026)
4.3 Americas Bio-based MDI Sales Growth
4.4 APAC Bio-based MDI Sales Growth
4.5 Europe Bio-based MDI Sales Growth
4.6 Middle East & Africa Bio-based MDI Sales Growth

5 AMERICAS

5.1 Americas Bio-based MDI Sales by Country
  5.1.1 Americas Bio-based MDI Sales by Country (2021-2026)
  5.1.2 Americas Bio-based MDI Revenue by Country (2021-2026)
5.2 Americas Bio-based MDI Sales by Type (2021-2026)
5.3 Americas Bio-based MDI Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Bio-based MDI Sales by Region
  6.1.1 APAC Bio-based MDI Sales by Region (2021-2026)
  6.1.2 APAC Bio-based MDI Revenue by Region (2021-2026)
6.2 APAC Bio-based MDI Sales by Type (2021-2026)
6.3 APAC Bio-based MDI Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Bio-based MDI by Country
  7.1.1 Europe Bio-based MDI Sales by Country (2021-2026)
  7.1.2 Europe Bio-based MDI Revenue by Country (2021-2026)
7.2 Europe Bio-based MDI Sales by Type (2021-2026)
7.3 Europe Bio-based MDI Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Bio-based MDI by Country
  8.1.1 Middle East & Africa Bio-based MDI Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Bio-based MDI Revenue by Country (2021-2026)
8.2 Middle East & Africa Bio-based MDI Sales by Type (2021-2026)
8.3 Middle East & Africa Bio-based MDI Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bio-based MDI
10.3 Manufacturing Process Analysis of Bio-based MDI
10.4 Industry Chain Structure of Bio-based MDI

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Bio-based MDI Distributors
11.3 Bio-based MDI Customer

12 WORLD FORECAST REVIEW FOR BIO-BASED MDI BY GEOGRAPHIC REGION

12.1 Global Bio-based MDI Market Size Forecast by Region
  12.1.1 Global Bio-based MDI Forecast by Region (2027-2032)
  12.1.2 Global Bio-based MDI Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Bio-based MDI Forecast by Type (2027-2032)
12.7 Global Bio-based MDI Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 BASF SE
  13.1.1 BASF SE Company Information
  13.1.2 BASF SE Bio-based MDI Product Portfolios and Specifications
  13.1.3 BASF SE Bio-based MDI Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 BASF SE Main Business Overview
  13.1.5 BASF SE Latest Developments
13.2 Covestro AG
  13.2.1 Covestro AG Company Information
  13.2.2 Covestro AG Bio-based MDI Product Portfolios and Specifications
  13.2.3 Covestro AG Bio-based MDI Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Covestro AG Main Business Overview
  13.2.5 Covestro AG Latest Developments
13.3 Dow Inc.
  13.3.1 Dow Inc. Company Information
  13.3.2 Dow Inc. Bio-based MDI Product Portfolios and Specifications
  13.3.3 Dow Inc. Bio-based MDI Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Dow Inc. Main Business Overview
  13.3.5 Dow Inc. Latest Developments
13.4 Huntsman Corporation
  13.4.1 Huntsman Corporation Company Information
  13.4.2 Huntsman Corporation Bio-based MDI Product Portfolios and Specifications
  13.4.3 Huntsman Corporation Bio-based MDI Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Huntsman Corporation Main Business Overview
  13.4.5 Huntsman Corporation Latest Developments
13.5 LANXESS
  13.5.1 LANXESS Company Information
  13.5.2 LANXESS Bio-based MDI Product Portfolios and Specifications
  13.5.3 LANXESS Bio-based MDI Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 LANXESS Main Business Overview
  13.5.5 LANXESS Latest Developments
13.6 Wanhua Chemical Group Co., Ltd.
  13.6.1 Wanhua Chemical Group Co., Ltd. Company Information
  13.6.2 Wanhua Chemical Group Co., Ltd. Bio-based MDI Product Portfolios and Specifications
  13.6.3 Wanhua Chemical Group Co., Ltd. Bio-based MDI Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Wanhua Chemical Group Co., Ltd. Main Business Overview
  13.6.5 Wanhua Chemical Group Co., Ltd. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Bio-based MDI Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Bio-based MDI Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Polymeric MDI
Table 4. Major Players of Monomeric MDI
Table 5. Major Players of Modified MDI
Table 6. Major Players of Others
Table 7. Global Bio-based MDI Sales by Type (2021-2026) & (Tons)
Table 8. Global Bio-based MDI Sales Market Share by Type (2021-2026)
Table 9. Global Bio-based MDI Revenue by Type (2021-2026) & ($ million)
Table 10. Global Bio-based MDI Revenue Market Share by Type (2021-2026)
Table 11. Global Bio-based MDI Sale Price by Type (2021-2026) & (US$/Ton)
Table 12. Major Players of Lignin-based MDI
Table 13. Major Players of Sugar/Carbohydrate-derived MDI
Table 14. Major Players of Others
Table 15. Global Bio-based MDI Sales by Feedstock Origin (2021-2026) & (Tons)
Table 16. Global Bio-based MDI Sales Market Share by Feedstock Origin (2021-2026)
Table 17. Global Bio-based MDI Revenue by Feedstock Origin (2021-2026) & ($ million)
Table 18. Global Bio-based MDI Revenue Market Share by Feedstock Origin (2021-2026)
Table 19. Global Bio-based MDI Sale Price by Feedstock Origin (2021-2026) & (US$/Ton)
Table 20. Major Players of Mass Balance
Table 21. Major Players of Bio-Circular Mass Balance
Table 22. Major Players of Physically Segregated
Table 23. Major Players of Others
Table 24. Global Bio-based MDI Sales by Renewable Attribute Route (2021-2026) & (Tons)
Table 25. Global Bio-based MDI Sales Market Share by Renewable Attribute Route (2021-2026)
Table 26. Global Bio-based MDI Revenue by Renewable Attribute Route (2021-2026) & ($ million)
Table 27. Global Bio-based MDI Revenue Market Share by Renewable Attribute Route (2021-2026)
Table 28. Global Bio-based MDI Sale Price by Renewable Attribute Route (2021-2026) & (US$/Ton)
Table 29. Global Bio-based MDI Sale by Application (2021-2026) & (Tons)
Table 30. Global Bio-based MDI Sale Market Share by Application (2021-2026)
Table 31. Global Bio-based MDI Revenue by Application (2021-2026) & ($ million)
Table 32. Global Bio-based MDI Revenue Market Share by Application (2021-2026)
Table 33. Global Bio-based MDI Sale Price by Application (2021-2026) & (US$/Ton)
Table 34. Global Bio-based MDI Sales by Company (2021-2026) & (Tons)
Table 35. Global Bio-based MDI Sales Market Share by Company (2021-2026)
Table 36. Global Bio-based MDI Revenue by Company (2021-2026) & ($ millions)
Table 37. Global Bio-based MDI Revenue Market Share by Company (2021-2026)
Table 38. Global Bio-based MDI Sale Price by Company (2021-2026) & (US$/Ton)
Table 39. Key Manufacturers Bio-based MDI Producing Area Distribution and Sales Area
Table 40. Players Bio-based MDI Products Offered
Table 41. Bio-based MDI Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 42. New Products and Potential Entrants
Table 43. Market M&A Activity & Strategy
Table 44. Global Bio-based MDI Sales by Geographic Region (2021-2026) & (Tons)
Table 45. Global Bio-based MDI Sales Market Share Geographic Region (2021-2026)
Table 46. Global Bio-based MDI Revenue by Geographic Region (2021-2026) & ($ millions)
Table 47. Global Bio-based MDI Revenue Market Share by Geographic Region (2021-2026)
Table 48. Global Bio-based MDI Sales by Country/Region (2021-2026) & (Tons)
Table 49. Global Bio-based MDI Sales Market Share by Country/Region (2021-2026)
Table 50. Global Bio-based MDI Revenue by Country/Region (2021-2026) & ($ millions)
Table 51. Global Bio-based MDI Revenue Market Share by Country/Region (2021-2026)
Table 52. Americas Bio-based MDI Sales by Country (2021-2026) & (Tons)
Table 53. Americas Bio-based MDI Sales Market Share by Country (2021-2026)
Table 54. Americas Bio-based MDI Revenue by Country (2021-2026) & ($ millions)
Table 55. Americas Bio-based MDI Sales by Type (2021-2026) & (Tons)
Table 56. Americas Bio-based MDI Sales by Application (2021-2026) & (Tons)
Table 57. APAC Bio-based MDI Sales by Region (2021-2026) & (Tons)
Table 58. APAC Bio-based MDI Sales Market Share by Region (2021-2026)
Table 59. APAC Bio-based MDI Revenue by Region (2021-2026) & ($ millions)
Table 60. APAC Bio-based MDI Sales by Type (2021-2026) & (Tons)
Table 61. APAC Bio-based MDI Sales by Application (2021-2026) & (Tons)
Table 62. Europe Bio-based MDI Sales by Country (2021-2026) & (Tons)
Table 63. Europe Bio-based MDI Revenue by Country (2021-2026) & ($ millions)
Table 64. Europe Bio-based MDI Sales by Type (2021-2026) & (Tons)
Table 65. Europe Bio-based MDI Sales by Application (2021-2026) & (Tons)
Table 66. Middle East & Africa Bio-based MDI Sales by Country (2021-2026) & (Tons)
Table 67. Middle East & Africa Bio-based MDI Revenue Market Share by Country (2021-2026)
Table 68. Middle East & Africa Bio-based MDI Sales by Type (2021-2026) & (Tons)
Table 69. Middle East & Africa Bio-based MDI Sales by Application (2021-2026) & (Tons)
Table 70. Key Market Drivers & Growth Opportunities of Bio-based MDI
Table 71. Key Market Challenges & Risks of Bio-based MDI
Table 72. Key Industry Trends of Bio-based MDI
Table 73. Bio-based MDI Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Bio-based MDI Distributors List
Table 76. Bio-based MDI Customer List
Table 77. Global Bio-based MDI Sales Forecast by Region (2027-2032) & (Tons)
Table 78. Global Bio-based MDI Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Americas Bio-based MDI Sales Forecast by Country (2027-2032) & (Tons)
Table 80. Americas Bio-based MDI Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. APAC Bio-based MDI Sales Forecast by Region (2027-2032) & (Tons)
Table 82. APAC Bio-based MDI Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 83. Europe Bio-based MDI Sales Forecast by Country (2027-2032) & (Tons)
Table 84. Europe Bio-based MDI Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Middle East & Africa Bio-based MDI Sales Forecast by Country (2027-2032) & (Tons)
Table 86. Middle East & Africa Bio-based MDI Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. Global Bio-based MDI Sales Forecast by Type (2027-2032) & (Tons)
Table 88. Global Bio-based MDI Revenue Forecast by Type (2027-2032) & ($ millions)
Table 89. Global Bio-based MDI Sales Forecast by Application (2027-2032) & (Tons)
Table 90. Global Bio-based MDI Revenue Forecast by Application (2027-2032) & ($ millions)
Table 91. BASF SE Basic Information, Bio-based MDI Manufacturing Base, Sales Area and Its Competitors
Table 92. BASF SE Bio-based MDI Product Portfolios and Specifications
Table 93. BASF SE Bio-based MDI Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 94. BASF SE Main Business
Table 95. BASF SE Latest Developments
Table 96. Covestro AG Basic Information, Bio-based MDI Manufacturing Base, Sales Area and Its Competitors
Table 97. Covestro AG Bio-based MDI Product Portfolios and Specifications
Table 98. Covestro AG Bio-based MDI Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 99. Covestro AG Main Business
Table 100. Covestro AG Latest Developments
Table 101. Dow Inc. Basic Information, Bio-based MDI Manufacturing Base, Sales Area and Its Competitors
Table 102. Dow Inc. Bio-based MDI Product Portfolios and Specifications
Table 103. Dow Inc. Bio-based MDI Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 104. Dow Inc. Main Business
Table 105. Dow Inc. Latest Developments
Table 106. Huntsman Corporation Basic Information, Bio-based MDI Manufacturing Base, Sales Area and Its Competitors
Table 107. Huntsman Corporation Bio-based MDI Product Portfolios and Specifications
Table 108. Huntsman Corporation Bio-based MDI Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 109. Huntsman Corporation Main Business
Table 110. Huntsman Corporation Latest Developments
Table 111. LANXESS Basic Information, Bio-based MDI Manufacturing Base, Sales Area and Its Competitors
Table 112. LANXESS Bio-based MDI Product Portfolios and Specifications
Table 113. LANXESS Bio-based MDI Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 114. LANXESS Main Business
Table 115. LANXESS Latest Developments
Table 116. Wanhua Chemical Group Co., Ltd. Basic Information, Bio-based MDI Manufacturing Base, Sales Area and Its Competitors
Table 117. Wanhua Chemical Group Co., Ltd. Bio-based MDI Product Portfolios and Specifications
Table 118. Wanhua Chemical Group Co., Ltd. Bio-based MDI Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 119. Wanhua Chemical Group Co., Ltd. Main Business
Table 120. Wanhua Chemical Group Co., Ltd. Latest Developments

LIST OF FIGURES

Figure 1. Picture of Bio-based MDI
Figure 2. Bio-based MDI Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bio-based MDI Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Bio-based MDI Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Bio-based MDI Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Bio-based MDI Sales Market Share by Country/Region (2025)
Figure 10. Bio-based MDI Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Polymeric MDI
Figure 12. Product Picture of Monomeric MDI
Figure 13. Product Picture of Modified MDI
Figure 14. Product Picture of Others
Figure 15. Global Bio-based MDI Sales Market Share by Type in 2026
Figure 16. Global Bio-based MDI Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Lignin-based MDI
Figure 18. Product Picture of Sugar/Carbohydrate-derived MDI
Figure 19. Product Picture of Others
Figure 20. Global Bio-based MDI Sales Market Share by Feedstock Origin in 2026
Figure 21. Global Bio-based MDI Revenue Market Share by Feedstock Origin (2021-2026)
Figure 22. Product Picture of Mass Balance
Figure 23. Product Picture of Bio-Circular Mass Balance
Figure 24. Product Picture of Physically Segregated
Figure 25. Product Picture of Others
Figure 26. Global Bio-based MDI Sales Market Share by Renewable Attribute Route in 2026
Figure 27. Global Bio-based MDI Revenue Market Share by Renewable Attribute Route (2021-2026)
Figure 28. Bio-based MDI Consumed in Construction Engineering
Figure 29. Global Bio-based MDI Market: Construction Engineering (2021-2026) & (Tons)
Figure 30. Bio-based MDI Consumed in Automobile Manufacturing
Figure 31. Global Bio-based MDI Market: Automobile Manufacturing (2021-2026) & (Tons)
Figure 32. Bio-based MDI Consumed in Shoe Manufacturing
Figure 33. Global Bio-based MDI Market: Shoe Manufacturing (2021-2026) & (Tons)
Figure 34. Bio-based MDI Consumed in Household Goods
Figure 35. Global Bio-based MDI Market: Household Goods (2021-2026) & (Tons)
Figure 36. Bio-based MDI Consumed in Others
Figure 37. Global Bio-based MDI Market: Others (2021-2026) & (Tons)
Figure 38. Global Bio-based MDI Sale Market Share by Application (2025)
Figure 39. Global Bio-based MDI Revenue Market Share by Application in 2025
Figure 40. Bio-based MDI Sales by Company in 2025 (Tons)
Figure 41. Global Bio-based MDI Sales Market Share by Company in 2025
Figure 42. Bio-based MDI Revenue by Company in 2025 ($ millions)
Figure 43. Global Bio-based MDI Revenue Market Share by Company in 2025
Figure 44. Global Bio-based MDI Sales Market Share by Geographic Region (2021-2026)
Figure 45. Global Bio-based MDI Revenue Market Share by Geographic Region in 2025
Figure 46. Americas Bio-based MDI Sales 2021-2026 (Tons)
Figure 47. Americas Bio-based MDI Revenue 2021-2026 ($ millions)
Figure 48. APAC Bio-based MDI Sales 2021-2026 (Tons)
Figure 49. APAC Bio-based MDI Revenue 2021-2026 ($ millions)
Figure 50. Europe Bio-based MDI Sales 2021-2026 (Tons)
Figure 51. Europe Bio-based MDI Revenue 2021-2026 ($ millions)
Figure 52. Middle East & Africa Bio-based MDI Sales 2021-2026 (Tons)
Figure 53. Middle East & Africa Bio-based MDI Revenue 2021-2026 ($ millions)
Figure 54. Americas Bio-based MDI Sales Market Share by Country in 2025
Figure 55. Americas Bio-based MDI Revenue Market Share by Country (2021-2026)
Figure 56. Americas Bio-based MDI Sales Market Share by Type (2021-2026)
Figure 57. Americas Bio-based MDI Sales Market Share by Application (2021-2026)
Figure 58. United States Bio-based MDI Revenue Growth 2021-2026 ($ millions)
Figure 59. Canada Bio-based MDI Revenue Growth 2021-2026 ($ millions)
Figure 60. Mexico Bio-based MDI Revenue Growth 2021-2026 ($ millions)
Figure 61. Brazil Bio-based MDI Revenue Growth 2021-2026 ($ millions)
Figure 62. APAC Bio-based MDI Sales Market Share by Region in 2025
Figure 63. APAC Bio-based MDI Revenue Market Share by Region (2021-2026)
Figure 64. APAC Bio-based MDI Sales Market Share by Type (2021-2026)
Figure 65. APAC Bio-based MDI Sales Market Share by Application (2021-2026)
Figure 66. China Bio-based MDI Revenue Growth 2021-2026 ($ millions)
Figure 67. Japan Bio-based MDI Revenue Growth 2021-2026 ($ millions)
Figure 68. South Korea Bio-based MDI Revenue Growth 2021-2026 ($ millions)
Figure 69. Southeast Asia Bio-based MDI Revenue Growth 2021-2026 ($ millions)
Figure 70. India Bio-based MDI Revenue Growth 2021-2026 ($ millions)
Figure 71. Australia Bio-based MDI Revenue Growth 2021-2026 ($ millions)
Figure 72. China Taiwan Bio-based MDI Revenue Growth 2021-2026 ($ millions)
Figure 73. Europe Bio-based MDI Sales Market Share by Country in 2025
Figure 74. Europe Bio-based MDI Revenue Market Share by Country (2021-2026)
Figure 75. Europe Bio-based MDI Sales Market Share by Type (2021-2026)
Figure 76. Europe Bio-based MDI Sales Market Share by Application (2021-2026)
Figure 77. Germany Bio-based MDI Revenue Growth 2021-2026 ($ millions)
Figure 78. France Bio-based MDI Revenue Growth 2021-2026 ($ millions)
Figure 79. UK Bio-based MDI Revenue Growth 2021-2026 ($ millions)
Figure 80. Italy Bio-based MDI Revenue Growth 2021-2026 ($ millions)
Figure 81. Russia Bio-based MDI Revenue Growth 2021-2026 ($ millions)
Figure 82. Middle East & Africa Bio-based MDI Sales Market Share by Country (2021-2026)
Figure 83. Middle East & Africa Bio-based MDI Sales Market Share by Type (2021-2026)
Figure 84. Middle East & Africa Bio-based MDI Sales Market Share by Application (2021-2026)
Figure 85. Egypt Bio-based MDI Revenue Growth 2021-2026 ($ millions)
Figure 86. South Africa Bio-based MDI Revenue Growth 2021-2026 ($ millions)
Figure 87. Israel Bio-based MDI Revenue Growth 2021-2026 ($ millions)
Figure 88. Turkey Bio-based MDI Revenue Growth 2021-2026 ($ millions)
Figure 89. GCC Countries Bio-based MDI Revenue Growth 2021-2026 ($ millions)
Figure 90. Manufacturing Cost Structure Analysis of Bio-based MDI in 2026
Figure 91. Manufacturing Process Analysis of Bio-based MDI
Figure 92. Industry Chain Structure of Bio-based MDI
Figure 93. Channels of Distribution
Figure 94. Global Bio-based MDI Sales Market Forecast by Region (2027-2032)
Figure 95. Global Bio-based MDI Revenue Market Share Forecast by Region (2027-2032)
Figure 96. Global Bio-based MDI Sales Market Share Forecast by Type (2027-2032)
Figure 97. Global Bio-based MDI Revenue Market Share Forecast by Type (2027-2032)
Figure 98. Global Bio-based MDI Sales Market Share Forecast by Application (2027-2032)
Figure 99. Global Bio-based MDI Revenue Market Share Forecast by Application (2027-2032)